Abstract: Systems and method for providing indications of trial-related attributes are provided. In embodiments, the method includes providing an indication to view a suggested clinical-trial criteria modification(s) that, if implemented, is expected to increase a number of patients eligible for a clinical trial. Thereafter, a suggested criterion modification for a clinical-trial criterion is received. The suggested criterion modification is based on a comparison of aggregated patient data associated with the clinical-trial criterion to the clinical-trial criterion. The indication of the suggested criterion modification for the clinical-trial criterion can be displayed.

Abstract: Systems and method for facilitating clinical-trial referrals are provided. In embodiments, the method includes searching clinical-trial data associated with a plurality of clinical trials to identify one or more clinical trials for which a patient is eligible to participate based on patient data associated with the patient. Such clinical-trial data associated with the plurality of clinical trials can be aggregated in a centralized data store. Thereafter, an indication of the one or more clinical trials for which the patient is eligible is provided.

Abstract: Systems and method for providing indications of trial-related attributes are provided. In embodiments, the method includes providing an indication to view a suggested clinical-trial criteria modification(s) that, if implemented, is expected to increase a number of patients eligible for a clinical trial. Thereafter, a suggested criterion modification for a clinical-trial criterion is received. The suggested criterion modification is based on a comparison of aggregated patient data associated with the clinical-trial criterion to the clinical-trial criterion. The indication of the suggested criterion modification for the clinical-trial criterion can be displayed.

Abstract: Embodiments relate to providing one or more recommended biological reagents in response to receiving a biological reagent order. An exemplary embodiment includes identifying biological reagents based on a biological reagent order that has been received. Characteristic data of the identified biological reagents may then be evaluated to identify a characteristic conflict among the identified biological reagents. Similarly, inventory data of the identified biological reagents may then be evaluated to identify an inventory conflict among the identified biological reagents. If a conflict, either characteristic or inventory, is identified, a recommendation for an alternative biological reagent may be provided that is free from conflict. Additionally, historical use data may be maintained and referenced to aid in identifying a biological reagent as either a potential biological reagent based on a suspected biological condition or as a substitute biological reagent.

Abstract: Embodiments relate to providing one or more recommended biological reagents in response to receiving a biological reagent order. An exemplary embodiment includes identifying biological reagents based on a biological reagent order that has been received. Characteristic data of the identified biological reagents may then be evaluated to identify a characteristic conflict among the identified biological reagents. Similarly, inventory data of the identified biological reagents may then be evaluated to identify an inventory conflict among the identified biological reagents. If a conflict, either characteristic or inventory, is identified, a recommendation for an alternative biological reagent may be provided that is free from conflict. Additionally, historical use data may be maintained and referenced to aid in identifying a biological reagent as either a potential biological reagent based on a suspected biological condition or as a substitute biological reagent.